Key result
Rivaroxaban use, complicated by drug interactions and multiple comorbidities, contributed to severe necrosis and delayed wound healing following a bicycle accident.
Why the study?
Although adverse effects of anticoagulants are recognized with standard risk factors, the impact of unexpected add-on risks in patients with controllable risks taking rivaroxaban required illustration.
Case Report (n=1)
No
Highlights the compounded bleeding and healing risks of rivaroxaban when combined with drug interactions (erythromycin) and unexpected trauma.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to rivaroxaban wound risks amid interactions and comorbidities post-trauma; hypothesis-generating for tailored anticoagulation in high-risk cases.
The negative effects of anticoagulants are well-known in patients with renal impairment, drug-drug interaction, lower physical conditions, and multiple comorbidities. We highlight that even in patients with controllable multiple risks for rivaroxaban use, add-on inevitable risks will lead to negative effects greater than those expected.
No takes yet. Share an insight, caveat, or question.
Abe et al. (2023) conducted a case report in Atrial fibrillation and multiple comorbidities (n=1). Rivaroxaban was evaluated on Wound healing and necrosis. Rivaroxaban use, complicated by drug interactions and multiple comorbidities, contributed to severe necrosis and delayed wound healing following a bicycle accident.
Synapse has enriched 10 related papers. Consider them for comparative context: